Reduced expression of mitochondrial complex I subunit Ndufs2 does not impact healthspan in mice

Gregory S. McElroy,Ram P. Chakrabarty,Karis B. D’Alessandro,Yuan-Shih Hu,Karthik Vasan,Jerica Tan,Joshua S. Stoolman,Samuel E. Weinberg,Elizabeth M. Steinert,Paul A. Reyfman,Benjamin D. Singer,Warren C. Ladiges,Lin Gao,José Lopéz-Barneo,Karen Ridge,G. R. Scott Budinger,Navdeep S. Chandel
DOI: https://doi.org/10.1038/s41598-022-09074-3
IF: 4.6
2022-03-25
Scientific Reports
Abstract:Abstract Aging in mammals leads to reduction in genes encoding the 45-subunit mitochondrial electron transport chain complex I. It has been hypothesized that normal aging and age-related diseases such as Parkinson’s disease are in part due to modest decrease in expression of mitochondrial complex I subunits. By contrast, diminishing expression of mitochondrial complex I genes in lower organisms increases lifespan. Furthermore, metformin, a putative complex I inhibitor, increases healthspan in mice and humans. In the present study, we investigated whether loss of one allele of Ndufs2 , the catalytic subunit of mitochondrial complex I, impacts healthspan and lifespan in mice. Our results indicate that Ndufs2 hemizygous mice ( Ndufs2 +/− ) show no overt impairment in aging-related motor function, learning, tissue histology, organismal metabolism, or sensitivity to metformin in a C57BL6/J background. Despite a significant reduction of Ndufs2 mRNA, the mice do not demonstrate a significant decrease in complex I function. However, there are detectable transcriptomic changes in individual cell types and tissues due to loss of one allele of Ndufs2 . Our data indicate that a 50% decline in mRNA of the core mitochondrial complex I subunit Ndufs2 is neither beneficial nor detrimental to healthspan.
multidisciplinary sciences
What problem does this paper attempt to address?